Fig. 6From: A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular diseaseThe calibration curves of the derivation set (A) and the verification set (B)Back to article page